ArabFinance: October Pharma reported a 161% Year on Year leap in its net profit in 2020, according to the company’s unaudited financial statements filed to the Egyptian Exchange.
Net profit stood at EGP 88.26 in 2020, compared to EGP 33.8 million achieved in 2019.
On December 9th, the company approved the budget of 2021, targeting net profit after tax of EGP 91.4 million.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.